Italy· 025540016
SUPREFACT*1 fiala SC 5,5 ml 1 mg/ml
A buserelin product containing buserelin, registered in Italy by CHEPLAPHARM ARZNEIMITTEL GMBH, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Buserelin is registered in 8 of 19 countries.
Countries holding a registration under ATC L02AE01 (buserelin), each read from that country’s own register.
- This record: Italy
- 4 of them publish a price we can compare per daily dose
Buserelin · ATC L02AE01
8 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Netherlands
- United Kingdom
The record
At a glance
- Active substance
- Buserelin
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL GMBH
- Country
- Italy (IT)
- ATC code
- L02AE01
- ATC class
- Buserelin
- Defined daily dose
- 0.11 mg, Implantat
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic025540016SUPREFACT*1 fiala SC 5,5 ml 1 mg/mlEUR 19.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Buserelin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBusol vetaniMedica GmbH
- United KingdomBuserelin 5.5mg/5.5ml solution for injection vialsAlliance Healthcare (Distribution) Ltd
- SwedenSuprecur 0,15 mg/dos Nässpray, lösningCheplapharm Arzneimittel GmbH
- SpainSUPREFACT 1 mg/ml SOLUCION INYECTABLECheplapharm Arzneimittel Gmbh
- GermanyMetrelefCheplapharm Arzneimittel Gmbh
- NetherlandsSuprefact Depot 3 maanden, implantatiestift 9,45 mgMedcor Pharmaceuticals B.V.
- CanadaSUPREFACTCHEPLAPHARM ARZNEIMITTEL GMBH
- BelgiumSuprefact Nasal 0.1 mgSanofi Belgium
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Suprecur, Suprefact
- Bulgaria · Супрефакт Депо 3 Месеца
- Germany · Profact Depot, Profact Pro Injectione
- Spain · Suprefact, Suprefact Depot
- United Kingdom (Northern Ireland) · Buserelin, Suprecur Injection
- Greece · Suprefact Depot 3 Μήνεσ
- Hungary · Suprefact
- Netherlands · Suprefact Depot
- Sweden · Suprecur, Suprefact
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4aa74848-595e-4ef5-82eb-6664df252969 GET /v1/drugs/4aa74848-595e-4ef5-82eb-6664df252969?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 19.33,
"source": "aifa",
"currency": "EUR",
"strength": "BUSERELIN 1MG/ML 5,5ML 1 UNITA' USO PARENTERALE",
"substance": "Buserelin",
"equivalence_group": "IJB",
"transparency_flag": null
}See everything about buserelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.